JP2002540204A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002540204A5 JP2002540204A5 JP2000608007A JP2000608007A JP2002540204A5 JP 2002540204 A5 JP2002540204 A5 JP 2002540204A5 JP 2000608007 A JP2000608007 A JP 2000608007A JP 2000608007 A JP2000608007 A JP 2000608007A JP 2002540204 A5 JP2002540204 A5 JP 2002540204A5
- Authority
- JP
- Japan
- Prior art keywords
- piperidinyl
- ethyl
- dichlorophenoxy
- amino
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 cyano, hydroxyl Chemical group 0.000 description 72
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 50
- 150000001875 compounds Chemical class 0.000 description 22
- 150000003839 salts Chemical class 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 9
- 239000012453 solvate Substances 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 7
- 125000005843 halogen group Chemical group 0.000 description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 3
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 description 2
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- BPPZIPHINXIUFJ-UHFFFAOYSA-N [1-[2-[(5-chloro-1,3-dimethylpyrazol-4-yl)methylamino]ethyl]piperidin-4-yl]-(4-chlorophenyl)methanone Chemical compound CC1=NN(C)C(Cl)=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 BPPZIPHINXIUFJ-UHFFFAOYSA-N 0.000 description 2
- 125000004450 alkenylene group Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- MHIFSXJQGYPPDB-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-fluorobenzamide Chemical compound C1=CC(F)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 MHIFSXJQGYPPDB-UHFFFAOYSA-N 0.000 description 2
- FTAFETTVRQXSRZ-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-methoxybenzamide Chemical compound C1=CC(OC)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 FTAFETTVRQXSRZ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Chemical group 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000005030 pyridylthio group Chemical group N1=C(C=CC=C1)S* 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 229910052717 sulfur Chemical group 0.000 description 2
- 239000011593 sulfur Chemical group 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- CCEKWQBFPXXKBN-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-(2-methylpropylamino)ethyl]piperidin-4-yl]methanone Chemical compound C1CN(CCNCC(C)C)CCC1C(=O)C1=CC=C(Cl)C=C1 CCEKWQBFPXXKBN-UHFFFAOYSA-N 0.000 description 1
- QWDIDFWRSBMBFV-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-(3-methylsulfanylbutylamino)ethyl]piperidin-4-yl]methanone Chemical compound C1CN(CCNCCC(C)SC)CCC1C(=O)C1=CC=C(Cl)C=C1 QWDIDFWRSBMBFV-UHFFFAOYSA-N 0.000 description 1
- CBFALSMXAFBKBY-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-(pyridin-2-ylmethylamino)ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2N=CC=CC=2)CC1 CBFALSMXAFBKBY-UHFFFAOYSA-N 0.000 description 1
- HIRXHSWOYNEDIE-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-(pyridin-4-ylmethylamino)ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C=CN=CC=2)CC1 HIRXHSWOYNEDIE-UHFFFAOYSA-N 0.000 description 1
- DPZYXLJALIJPHJ-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-(quinolin-3-ylmethylamino)ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C=C3C=CC=CC3=NC=2)CC1 DPZYXLJALIJPHJ-UHFFFAOYSA-N 0.000 description 1
- CAMLOMWWSRNMDR-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(1-methylbenzimidazol-2-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound N=1C2=CC=CC=C2N(C)C=1CNCCN(CC1)CCC1C(=O)C1=CC=C(Cl)C=C1 CAMLOMWWSRNMDR-UHFFFAOYSA-N 0.000 description 1
- RMTAXKXHFKSHPJ-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2,4-dimethoxypyrimidin-5-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound COC1=NC(OC)=NC=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 RMTAXKXHFKSHPJ-UHFFFAOYSA-N 0.000 description 1
- BZZQZDAWAXXDRW-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2,5-difluorophenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound FC1=CC=C(F)C(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 BZZQZDAWAXXDRW-UHFFFAOYSA-N 0.000 description 1
- QNHDEZAQQYUODX-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2,6-dichlorophenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C(=CC=CC=2Cl)Cl)CC1 QNHDEZAQQYUODX-UHFFFAOYSA-N 0.000 description 1
- PLIWJSGXSUYJCZ-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2,6-dichloropyridin-4-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C=C(Cl)N=C(Cl)C=2)CC1 PLIWJSGXSUYJCZ-UHFFFAOYSA-N 0.000 description 1
- FIHOVKRJUWICRZ-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2-chloroquinolin-3-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C(=NC3=CC=CC=C3C=2)Cl)CC1 FIHOVKRJUWICRZ-UHFFFAOYSA-N 0.000 description 1
- CCKAMSOSAWJYBF-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2-fluoro-4,5-dimethoxyphenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=C(OC)C(OC)=CC(F)=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 CCKAMSOSAWJYBF-UHFFFAOYSA-N 0.000 description 1
- FBZOJNNRWXMQGT-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2-phenyl-1h-imidazol-5-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2N=C(NC=2)C=2C=CC=CC=2)CC1 FBZOJNNRWXMQGT-UHFFFAOYSA-N 0.000 description 1
- CRHYLKKTXOMRKU-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2-phenylpyrazol-3-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2N(N=CC=2)C=2C=CC=CC=2)CC1 CRHYLKKTXOMRKU-UHFFFAOYSA-N 0.000 description 1
- NIRSYNGGTPBPRP-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3,4,5-trimethoxyphenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound COC1=C(OC)C(OC)=CC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 NIRSYNGGTPBPRP-UHFFFAOYSA-N 0.000 description 1
- BQSJOJBQVLBVLW-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3,5-difluorophenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound FC1=CC(F)=CC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 BQSJOJBQVLBVLW-UHFFFAOYSA-N 0.000 description 1
- GQWDJTMFSZHGMX-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3-hydroxy-4-methoxyphenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=C(O)C(OC)=CC=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 GQWDJTMFSZHGMX-UHFFFAOYSA-N 0.000 description 1
- NTICZMKTSNVWMT-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3-hydroxy-4-nitrophenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=C([N+]([O-])=O)C(O)=CC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 NTICZMKTSNVWMT-UHFFFAOYSA-N 0.000 description 1
- LRKHJDIAAFTZID-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3-methylthiophen-2-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CSC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1C LRKHJDIAAFTZID-UHFFFAOYSA-N 0.000 description 1
- IRHNODZMYZXIQC-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3-nitro-4-pyridin-2-ylsulfanylphenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C=1C=C(SC=2N=CC=CC=2)C([N+](=O)[O-])=CC=1CNCCN(CC1)CCC1C(=O)C1=CC=C(Cl)C=C1 IRHNODZMYZXIQC-UHFFFAOYSA-N 0.000 description 1
- ZGEADYISVFOZKM-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3-nitrophenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound [O-][N+](=O)C1=CC=CC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 ZGEADYISVFOZKM-UHFFFAOYSA-N 0.000 description 1
- SNSLWGMYHQXIKB-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(4-nitrophenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 SNSLWGMYHQXIKB-UHFFFAOYSA-N 0.000 description 1
- LALDGZAOEXVHEY-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(4-phenylpiperidin-4-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC2(CCNCC2)C=2C=CC=CC=2)CC1 LALDGZAOEXVHEY-UHFFFAOYSA-N 0.000 description 1
- QQZVTJZQPKPZAV-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(5-ethylthiophen-2-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound S1C(CC)=CC=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 QQZVTJZQPKPZAV-UHFFFAOYSA-N 0.000 description 1
- OVNYNSHJGJUENX-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(5-nitro-2-pyridin-2-ylsulfanylphenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1CC(C(=O)C=2C=CC(Cl)=CC=2)CCN1CCNCC1=CC([N+](=O)[O-])=CC=C1SC1=CC=CC=N1 OVNYNSHJGJUENX-UHFFFAOYSA-N 0.000 description 1
- PSTVENQTOPIJHX-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(6-methylpyridin-2-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound CC1=CC=CC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=N1 PSTVENQTOPIJHX-UHFFFAOYSA-N 0.000 description 1
- LQNLIYRHRPZSPL-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(6-nitro-1,3-benzodioxol-5-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound [O-][N+](=O)C1=CC=2OCOC=2C=C1CNCCN(CC1)CCC1C(=O)C1=CC=C(Cl)C=C1 LQNLIYRHRPZSPL-UHFFFAOYSA-N 0.000 description 1
- PFYFSSBSMWQHOT-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(7-hydroxy-3,7-dimethyloctyl)amino]ethyl]piperidin-4-yl]methanone Chemical compound C1CN(CCNCCC(CCCC(C)(C)O)C)CCC1C(=O)C1=CC=C(Cl)C=C1 PFYFSSBSMWQHOT-UHFFFAOYSA-N 0.000 description 1
- USCYTAXQSSZRJK-OWOJBTEDSA-N (4-chlorophenyl)-[1-[2-[[(e)-3-(4-nitrophenyl)prop-2-enyl]amino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1\C=C\CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 USCYTAXQSSZRJK-OWOJBTEDSA-N 0.000 description 1
- NTMOXDJIDPKQKQ-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[[5-(3-nitrophenyl)furan-2-yl]methylamino]ethyl]piperidin-4-yl]methanone Chemical compound [O-][N+](=O)C1=CC=CC(C=2OC(CNCCN3CCC(CC3)C(=O)C=3C=CC(Cl)=CC=3)=CC=2)=C1 NTMOXDJIDPKQKQ-UHFFFAOYSA-N 0.000 description 1
- 125000006677 (C1-C3) haloalkoxy group Chemical group 0.000 description 1
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 description 1
- ZWXDDWDWMCESKH-RMKNXTFCSA-N (e)-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-phenylprop-2-enamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)\C=C\C=2C=CC=CC=2)CC1 ZWXDDWDWMCESKH-RMKNXTFCSA-N 0.000 description 1
- GNTLPZAHICFRRC-XCVCLJGOSA-N (e)-n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-3-(4-nitrophenyl)prop-2-enamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1\C=C\C(=O)NCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 GNTLPZAHICFRRC-XCVCLJGOSA-N 0.000 description 1
- ZOPXEBJEWRETPJ-IZZDOVSWSA-N (e)-n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-3-phenylprop-2-enamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)\C=C\C=2C=CC=CC=2)CC1 ZOPXEBJEWRETPJ-IZZDOVSWSA-N 0.000 description 1
- HKNFOAKZDXBKRA-UHFFFAOYSA-N 2,6-dimethyl-1H-pyrimidine-2,4-diamine Chemical compound CC1(NC(=CC(=N1)N)C)N HKNFOAKZDXBKRA-UHFFFAOYSA-N 0.000 description 1
- BMHUXUQPWBADAL-UHFFFAOYSA-N 2-[2-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]-4-nitrophenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C([N+]([O-])=O)C=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 BMHUXUQPWBADAL-UHFFFAOYSA-N 0.000 description 1
- GUXFOLSWRZODOX-UHFFFAOYSA-N 2-[3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-2,4-dioxoquinazolin-1-yl]-n,n-dimethylacetamide;hydrochloride Chemical compound Cl.O=C1N(CC(=O)N(C)C)C2=CC=CC=C2C(=O)N1CCN(CC1)CCC1C(=O)C1=CC=C(F)C=C1 GUXFOLSWRZODOX-UHFFFAOYSA-N 0.000 description 1
- NSFBBZNOSVHEES-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-n-[(3-methoxyphenyl)methyl]ethanamine;dihydrochloride Chemical compound Cl.Cl.COC1=CC=CC(CNCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 NSFBBZNOSVHEES-UHFFFAOYSA-N 0.000 description 1
- XNGVLISOMZWKAQ-UHFFFAOYSA-N 2-[[2-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propylamino]pyrimidin-4-yl]-methylamino]ethanol Chemical compound OCCN(C)C1=CC=NC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 XNGVLISOMZWKAQ-UHFFFAOYSA-N 0.000 description 1
- OLFUWQFGAVROEA-UHFFFAOYSA-N 2-[[2-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propylamino]pyrimidin-4-yl]amino]ethanol Chemical compound OCCNC1=CC=NC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 OLFUWQFGAVROEA-UHFFFAOYSA-N 0.000 description 1
- PVPXVESRTMPRRZ-UHFFFAOYSA-N 2-[[4-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethylamino]pyrimidin-2-yl]-methylamino]ethanol Chemical compound OCCN(C)C1=NC=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 PVPXVESRTMPRRZ-UHFFFAOYSA-N 0.000 description 1
- ZNLBTLXZEMUXOG-UHFFFAOYSA-N 2-[[4-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethylamino]pyrimidin-2-yl]amino]ethanol Chemical compound OCCNC1=NC=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 ZNLBTLXZEMUXOG-UHFFFAOYSA-N 0.000 description 1
- SSDVFNNGIZCJGU-UHFFFAOYSA-N 2-[[4-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propylamino]pyrimidin-2-yl]-methylamino]ethanol Chemical compound OCCN(C)C1=NC=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 SSDVFNNGIZCJGU-UHFFFAOYSA-N 0.000 description 1
- VVWOJGLYFQOSHE-UHFFFAOYSA-N 2-[[4-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propylamino]pyrimidin-2-yl]amino]ethanol Chemical compound OCCNC1=NC=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 VVWOJGLYFQOSHE-UHFFFAOYSA-N 0.000 description 1
- QPIPEHZSHGDUEL-UHFFFAOYSA-N 2-acetamido-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1,3-thiazole-4-carboxamide Chemical compound S1C(NC(=O)C)=NC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 QPIPEHZSHGDUEL-UHFFFAOYSA-N 0.000 description 1
- PFODAJFKGNHIKF-UHFFFAOYSA-N 2-amino-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1,3-thiazole-4-carboxamide Chemical compound S1C(N)=NC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 PFODAJFKGNHIKF-UHFFFAOYSA-N 0.000 description 1
- WFTYOJFJHQSUGC-UHFFFAOYSA-N 2-bromo-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-5-methoxybenzamide Chemical compound COC1=CC=C(Br)C(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 WFTYOJFJHQSUGC-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- ZJWLHFWEFOMZAL-UHFFFAOYSA-N 3-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-6-methoxy-1h-quinazoline-2,4-dione Chemical compound O=C1C2=CC(OC)=CC=C2NC(=O)N1CCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 ZJWLHFWEFOMZAL-UHFFFAOYSA-N 0.000 description 1
- QWSWUJUPZKKMCB-UHFFFAOYSA-N 3-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]-6,7-dimethylchromen-4-one Chemical compound O=C1C=2C=C(C)C(C)=CC=2OC=C1CNCCN(CC1)CCC1C(=O)C1=CC=C(Cl)C=C1 QWSWUJUPZKKMCB-UHFFFAOYSA-N 0.000 description 1
- KFFDPUVRJFFJRV-UHFFFAOYSA-N 3-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]chromen-4-one Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C(C3=CC=CC=C3OC=2)=O)CC1 KFFDPUVRJFFJRV-UHFFFAOYSA-N 0.000 description 1
- JXLSUJLHSUIKHP-UHFFFAOYSA-N 3-amino-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-methoxybenzamide Chemical compound C1=C(N)C(OC)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 JXLSUJLHSUIKHP-UHFFFAOYSA-N 0.000 description 1
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 1
- UXWWZPILDBNLQO-UHFFFAOYSA-N 3-chloro-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]benzamide;hydrochloride Chemical compound Cl.ClC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 UXWWZPILDBNLQO-UHFFFAOYSA-N 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- APSKKFUPDZBWNV-UHFFFAOYSA-N 4-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]-1,5-dimethyl-2-phenylpyrazol-3-one Chemical compound O=C1N(C=2C=CC=CC=2)N(C)C(C)=C1CNCCN(CC1)CCC1C(=O)C1=CC=C(Cl)C=C1 APSKKFUPDZBWNV-UHFFFAOYSA-N 0.000 description 1
- SOURVZNLNIJWDC-UHFFFAOYSA-N 4-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]-4-ethylhexanenitrile Chemical compound C1CN(CCNCC(CC)(CCC#N)CC)CCC1C(=O)C1=CC=C(Cl)C=C1 SOURVZNLNIJWDC-UHFFFAOYSA-N 0.000 description 1
- BAXBAKNPTIKXDR-UHFFFAOYSA-N 4-amino-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methoxybenzamide Chemical compound C1=C(N)C(OC)=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 BAXBAKNPTIKXDR-UHFFFAOYSA-N 0.000 description 1
- MSLRDSZTCIDZOZ-UHFFFAOYSA-N 4-chloro-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-[2-(dimethylamino)-2-oxoethoxy]benzamide Chemical compound CN(C)C(=O)COC1=CC(Cl)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 MSLRDSZTCIDZOZ-UHFFFAOYSA-N 0.000 description 1
- LXRQUFJGFDAHOE-UHFFFAOYSA-N 4-chloro-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methoxybenzamide Chemical compound C1=C(Cl)C(OC)=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 LXRQUFJGFDAHOE-UHFFFAOYSA-N 0.000 description 1
- JHZCXLDNXHWXJA-UHFFFAOYSA-N 4-chloro-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-nitrobenzamide Chemical compound C1=C(Cl)C([N+](=O)[O-])=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 JHZCXLDNXHWXJA-UHFFFAOYSA-N 0.000 description 1
- UDLQORCFOQLNRB-UHFFFAOYSA-N 5-bromo-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]furan-2-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2OC(Br)=CC=2)CC1 UDLQORCFOQLNRB-UHFFFAOYSA-N 0.000 description 1
- NPMFBHDRRWILOH-UHFFFAOYSA-N 5-chloro-n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]pyridin-2-amine Chemical compound N1=CC(Cl)=CC=C1NCCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 NPMFBHDRRWILOH-UHFFFAOYSA-N 0.000 description 1
- MNMGURNXXQQXDV-UHFFFAOYSA-N 6-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethylamino]-1,3-dimethylpyrimidine-2,4-dione Chemical compound O=C1N(C)C(=O)N(C)C(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 MNMGURNXXQQXDV-UHFFFAOYSA-N 0.000 description 1
- MMXKXXGRZUAQGP-UHFFFAOYSA-N 6-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione Chemical compound O=C1N(C)C(=O)N(C)C(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 MMXKXXGRZUAQGP-UHFFFAOYSA-N 0.000 description 1
- AWFDLYTZOASVKX-UHFFFAOYSA-N 6-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]-2-methylsulfanylpyridine-3-carbonitrile Chemical compound C1=C(C#N)C(SC)=NC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 AWFDLYTZOASVKX-UHFFFAOYSA-N 0.000 description 1
- ATAPQCXFQQJJQF-UHFFFAOYSA-N 6-chloro-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]pyrazin-2-amine Chemical compound ClC1=CN=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 ATAPQCXFQQJJQF-UHFFFAOYSA-N 0.000 description 1
- GDPQAWMLYMBYKE-UHFFFAOYSA-N 6-chloro-n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]pyridazin-3-amine Chemical compound N1=NC(Cl)=CC=C1NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 GDPQAWMLYMBYKE-UHFFFAOYSA-N 0.000 description 1
- WWRGONNHZFUSAT-UHFFFAOYSA-N 6-chloro-n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]pyrazin-2-amine Chemical compound ClC1=CN=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 WWRGONNHZFUSAT-UHFFFAOYSA-N 0.000 description 1
- DYXDOWBDPGAJHK-UHFFFAOYSA-N 6-chloro-n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]pyridazin-3-amine Chemical compound N1=NC(Cl)=CC=C1NCCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 DYXDOWBDPGAJHK-UHFFFAOYSA-N 0.000 description 1
- OVGRJQQHTOESDL-UHFFFAOYSA-N 6-chloro-n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]pyridin-2-amine Chemical compound ClC1=CC=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 OVGRJQQHTOESDL-UHFFFAOYSA-N 0.000 description 1
- 102000052567 Anaphase-Promoting Complex-Cyclosome Apc1 Subunit Human genes 0.000 description 1
- 125000003830 C1- C4 alkylcarbonylamino group Chemical group 0.000 description 1
- 102000009410 Chemokine receptor Human genes 0.000 description 1
- 108050000299 Chemokine receptor Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RATAYRRRZOWEPY-UHFFFAOYSA-N N-[1-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-3-methylbutan-2-yl]-4-methylbenzamide hydrochloride Chemical compound Cl.CC(C)C(CN1CCC(CC1)Oc1ccc(Cl)c(Cl)c1)NC(=O)c1ccc(C)cc1 RATAYRRRZOWEPY-UHFFFAOYSA-N 0.000 description 1
- 108091006463 SLC25A24 Proteins 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- YLGDPKLRWDOCHX-UHFFFAOYSA-N [1-[2-[(2-chloro-6-fluorophenyl)methylamino]ethyl]piperidin-4-yl]-(4-chlorophenyl)methanone Chemical compound FC1=CC=CC(Cl)=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 YLGDPKLRWDOCHX-UHFFFAOYSA-N 0.000 description 1
- XRJGJSBHSFQMHU-UHFFFAOYSA-N [1-[2-[(4-bromo-1h-pyrazol-5-yl)methylamino]ethyl]piperidin-4-yl]-(4-chlorophenyl)methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C(=CNN=2)Br)CC1 XRJGJSBHSFQMHU-UHFFFAOYSA-N 0.000 description 1
- XCKQLBGYDBLQCS-UHFFFAOYSA-N [1-[2-[[5-chloro-1-methyl-3-(trifluoromethyl)pyrazol-4-yl]methylamino]ethyl]piperidin-4-yl]-(4-chlorophenyl)methanone Chemical compound CN1N=C(C(F)(F)F)C(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1Cl XCKQLBGYDBLQCS-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- NZNMSOFKMUBTKW-UHFFFAOYSA-M cyclohexanecarboxylate Chemical compound [O-]C(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-M 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000004820 halides Chemical group 0.000 description 1
- 125000004438 haloalkoxy group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- NSKZINWLPRKWDC-UHFFFAOYSA-N methyl 4-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethylamino]-4-oxobutanoate Chemical compound C1CN(CCNC(=O)CCC(=O)OC)CCC1OC1=CC=C(Cl)C(Cl)=C1 NSKZINWLPRKWDC-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- BLRWPDDIYQWCLQ-UHFFFAOYSA-N n-[1-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-3-methylbutan-2-yl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC(CN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)C(C)C)=C1 BLRWPDDIYQWCLQ-UHFFFAOYSA-N 0.000 description 1
- KETMPDYDKCWDQW-UHFFFAOYSA-N n-[2-[4-(3,4-dichloroanilino)piperidin-1-yl]ethyl]-3-methoxybenzamide;dihydrochloride Chemical compound Cl.Cl.COC1=CC=CC(C(=O)NCCN2CCC(CC2)NC=2C=C(Cl)C(Cl)=CC=2)=C1 KETMPDYDKCWDQW-UHFFFAOYSA-N 0.000 description 1
- NVFNOMAXNHPMEV-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorobenzoyl)piperazin-1-yl]ethyl]-3-methoxybenzamide;hydrochloride Chemical compound Cl.COC1=CC=CC(C(=O)NCCN2CCN(CC2)C(=O)C=2C=C(Cl)C(Cl)=CC=2)=C1 NVFNOMAXNHPMEV-UHFFFAOYSA-N 0.000 description 1
- QIIHHUHGQJPRND-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1,3-benzodioxole-5-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2C=C3OCOC3=CC=2)CC1 QIIHHUHGQJPRND-UHFFFAOYSA-N 0.000 description 1
- KWXJUNDUJSJTBH-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1,3-benzothiazol-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2SC3=CC=CC=C3N=2)CC1 KWXJUNDUJSJTBH-UHFFFAOYSA-N 0.000 description 1
- QLDSETCYASKHSM-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1,3-benzoxazol-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2OC3=CC=CC=C3N=2)CC1 QLDSETCYASKHSM-UHFFFAOYSA-N 0.000 description 1
- KQSSUXAOULQXIV-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1,8-naphthyridin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2N=C3N=CC=CC3=CC=2)CC1 KQSSUXAOULQXIV-UHFFFAOYSA-N 0.000 description 1
- SJDLHXHEAZDEPB-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1-methylpyrazolo[3,4-d]pyrimidin-4-amine Chemical compound N1=CN=C2N(C)N=CC2=C1NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 SJDLHXHEAZDEPB-UHFFFAOYSA-N 0.000 description 1
- ZISSECHEDKXQAI-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1h-imidazole-5-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2N=CNC=2)CC1 ZISSECHEDKXQAI-UHFFFAOYSA-N 0.000 description 1
- LGAZSGRGURZRHR-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2,4-difluorobenzamide Chemical compound FC1=CC(F)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 LGAZSGRGURZRHR-UHFFFAOYSA-N 0.000 description 1
- PCKWFEMVMVVWBW-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2,4-dimethyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C)=NC(C)=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 PCKWFEMVMVVWBW-UHFFFAOYSA-N 0.000 description 1
- VNNOZQFEDPIYTO-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2,5-dimethyl-1,3-oxazole-4-carboxamide Chemical compound O1C(C)=NC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1C VNNOZQFEDPIYTO-UHFFFAOYSA-N 0.000 description 1
- ISWAUFMGBSNAHJ-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2,6-dimethoxypyrimidin-4-amine Chemical compound COC1=NC(OC)=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 ISWAUFMGBSNAHJ-UHFFFAOYSA-N 0.000 description 1
- LHCHQRNVSKTWFV-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-(methylsulfanylmethyl)pyrimidin-4-amine Chemical compound CSCC1=NC=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 LHCHQRNVSKTWFV-UHFFFAOYSA-N 0.000 description 1
- JVSQVHSJEFXFRT-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-iodobenzamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2C(=CC=CC=2)I)CC1 JVSQVHSJEFXFRT-UHFFFAOYSA-N 0.000 description 1
- OABROTVIJSOZCG-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-methoxyacetamide Chemical compound C1CN(CCNC(=O)COC)CCC1OC1=CC=C(Cl)C(Cl)=C1 OABROTVIJSOZCG-UHFFFAOYSA-N 0.000 description 1
- MQERTRHDLBTFFH-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-methoxybenzamide Chemical compound COC1=CC=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 MQERTRHDLBTFFH-UHFFFAOYSA-N 0.000 description 1
- DYGZKAWWMOSVJK-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 DYGZKAWWMOSVJK-UHFFFAOYSA-N 0.000 description 1
- VOEFLKXNTZWMOY-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-methylsulfanylpyrimidin-4-amine Chemical compound CSC1=NC=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 VOEFLKXNTZWMOY-UHFFFAOYSA-N 0.000 description 1
- JCZWLPKVMPQFQD-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-nitrobenzamide Chemical compound [O-][N+](=O)C1=CC=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 JCZWLPKVMPQFQD-UHFFFAOYSA-N 0.000 description 1
- CUCPXUJTZQFAEV-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-phenoxyacetamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)COC=2C=CC=CC=2)CC1 CUCPXUJTZQFAEV-UHFFFAOYSA-N 0.000 description 1
- FBTMKTZWRAXPLD-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-phenylacetamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)CC=2C=CC=CC=2)CC1 FBTMKTZWRAXPLD-UHFFFAOYSA-N 0.000 description 1
- MRTWXQBKCWYQLW-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-phenylacetamide;hydrochloride Chemical compound Cl.C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)CC=2C=CC=CC=2)CC1 MRTWXQBKCWYQLW-UHFFFAOYSA-N 0.000 description 1
- WUBLBLSCBTYXAY-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-pyridin-4-yl-1,3-thiazole-4-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2N=C(SC=2)C=2C=CN=CC=2)CC1 WUBLBLSCBTYXAY-UHFFFAOYSA-N 0.000 description 1
- HCZDPNORRYKRTB-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3,5-difluorobenzamide Chemical compound FC1=CC(F)=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 HCZDPNORRYKRTB-UHFFFAOYSA-N 0.000 description 1
- ZZJXRWKPAZSRJC-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3,5-dinitrobenzamide Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 ZZJXRWKPAZSRJC-UHFFFAOYSA-N 0.000 description 1
- BIWQWPKNOLOQCG-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-ethoxybenzamide;hydrochloride Chemical compound Cl.CCOC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 BIWQWPKNOLOQCG-UHFFFAOYSA-N 0.000 description 1
- SBCGODLUNFOCIX-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-fluoro-4-methoxybenzamide Chemical compound C1=C(F)C(OC)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 SBCGODLUNFOCIX-UHFFFAOYSA-N 0.000 description 1
- KBKXFOOUOMDXLU-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-fluorobenzamide Chemical compound FC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 KBKXFOOUOMDXLU-UHFFFAOYSA-N 0.000 description 1
- CBWVUHWMSNTREN-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-fluorobenzamide;hydrochloride Chemical compound Cl.FC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 CBWVUHWMSNTREN-UHFFFAOYSA-N 0.000 description 1
- SETIHLUZSWNKTG-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-hydroxybenzamide;hydrochloride Chemical compound Cl.OC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 SETIHLUZSWNKTG-UHFFFAOYSA-N 0.000 description 1
- LBJLDURINCUAHI-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methoxy-4-methylbenzamide Chemical compound C1=C(C)C(OC)=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 LBJLDURINCUAHI-UHFFFAOYSA-N 0.000 description 1
- WOCAUAGFAOCBHT-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 WOCAUAGFAOCBHT-UHFFFAOYSA-N 0.000 description 1
- HTVQOZOZAIYPRA-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methoxybenzamide;hydrochloride Chemical compound Cl.COC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 HTVQOZOZAIYPRA-UHFFFAOYSA-N 0.000 description 1
- YSRLFWOFKGYOFR-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methylbenzamide Chemical compound CC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 YSRLFWOFKGYOFR-UHFFFAOYSA-N 0.000 description 1
- YTUKBSHEPUURCK-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methylfuran-2-carboxamide Chemical compound C1=COC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1C YTUKBSHEPUURCK-UHFFFAOYSA-N 0.000 description 1
- DZAFQLBGKORWFO-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-phenylpropanamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)CCC=2C=CC=CC=2)CC1 DZAFQLBGKORWFO-UHFFFAOYSA-N 0.000 description 1
- MZVLWYDCCWHQFH-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4,5-dimethylfuran-2-carboxamide Chemical compound O1C(C)=C(C)C=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 MZVLWYDCCWHQFH-UHFFFAOYSA-N 0.000 description 1
- QOYIEWYJWVPSNB-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4,6-dimethoxypyrimidin-2-amine Chemical compound COC1=CC(OC)=NC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 QOYIEWYJWVPSNB-UHFFFAOYSA-N 0.000 description 1
- OJMHDQHNQCORBV-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-(furan-3-yl)pyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2N=C(C=CN=2)C2=COC=C2)CC1 OJMHDQHNQCORBV-UHFFFAOYSA-N 0.000 description 1
- FVYCULJCSOBDLR-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-(trifluoromethyl)pyrimidin-2-amine Chemical compound FC(F)(F)C1=CC=NC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 FVYCULJCSOBDLR-UHFFFAOYSA-N 0.000 description 1
- ZYHXWIHFKNVOSJ-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-ethoxybenzamide Chemical compound C1=CC(OCC)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 ZYHXWIHFKNVOSJ-UHFFFAOYSA-N 0.000 description 1
- MMRUIYLXLJUSGC-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-iodobenzamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2C=CC(I)=CC=2)CC1 MMRUIYLXLJUSGC-UHFFFAOYSA-N 0.000 description 1
- LSECCOKTVBGCPQ-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-methyl-3-nitrobenzamide Chemical compound C1=C([N+]([O-])=O)C(C)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 LSECCOKTVBGCPQ-UHFFFAOYSA-N 0.000 description 1
- VZWJVDVJJFOVHX-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-methylbenzamide Chemical compound C1=CC(C)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 VZWJVDVJJFOVHX-UHFFFAOYSA-N 0.000 description 1
- NMOPBBNBMLLCEV-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-nitrobenzamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 NMOPBBNBMLLCEV-UHFFFAOYSA-N 0.000 description 1
- REXMJLJELCTNFZ-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-phenylbutanamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)CCCC=2C=CC=CC=2)CC1 REXMJLJELCTNFZ-UHFFFAOYSA-N 0.000 description 1
- VEEOQIODRFAASP-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-phenylpyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2N=C(C=CN=2)C=2C=CC=CC=2)CC1 VEEOQIODRFAASP-UHFFFAOYSA-N 0.000 description 1
- RZTSRZKJOOOKMA-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-propan-2-yloxybenzamide Chemical compound C1=CC(OC(C)C)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 RZTSRZKJOOOKMA-UHFFFAOYSA-N 0.000 description 1
- ISOOYEFAGWGFOV-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-propylsulfanylpyrimidin-2-amine Chemical compound CCCSC1=CC=NC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 ISOOYEFAGWGFOV-UHFFFAOYSA-N 0.000 description 1
- ZGHGGEVGIQQCMZ-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-pyridin-3-ylpyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2N=C(C=CN=2)C=2C=NC=CC=2)CC1 ZGHGGEVGIQQCMZ-UHFFFAOYSA-N 0.000 description 1
- VNGXYAQDIVSFEJ-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-5-methoxy-1-benzofuran-2-carboxamide Chemical compound C=1C2=CC(OC)=CC=C2OC=1C(=O)NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 VNGXYAQDIVSFEJ-UHFFFAOYSA-N 0.000 description 1
- XHZUGNRUYREDGZ-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-5-methoxy-2-methylpyrimidin-4-amine Chemical compound COC1=CN=C(C)N=C1NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 XHZUGNRUYREDGZ-UHFFFAOYSA-N 0.000 description 1
- DJOYNOJKWBOLTJ-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-5-methoxy-2-methylsulfanylpyrimidin-4-amine Chemical compound COC1=CN=C(SC)N=C1NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 DJOYNOJKWBOLTJ-UHFFFAOYSA-N 0.000 description 1
- AHSSAFRUOLFUBM-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-5-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C=12C(C)=CSC2=NC=NC=1NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 AHSSAFRUOLFUBM-UHFFFAOYSA-N 0.000 description 1
- BNSSXUYAHFYQHZ-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-6-methyl-2-methylsulfanylpyrimidin-4-amine Chemical compound CSC1=NC(C)=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 BNSSXUYAHFYQHZ-UHFFFAOYSA-N 0.000 description 1
- LIMGNCBIBIFOEN-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-7-ethoxy-1-benzofuran-2-carboxamide Chemical compound O1C=2C(OCC)=CC=CC=2C=C1C(=O)NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 LIMGNCBIBIFOEN-UHFFFAOYSA-N 0.000 description 1
- CNUGRMNAHHHHRM-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-7-methoxy-1-benzofuran-2-carboxamide Chemical compound O1C=2C(OC)=CC=CC=2C=C1C(=O)NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 CNUGRMNAHHHHRM-UHFFFAOYSA-N 0.000 description 1
- OJZLSZAYGQCTEK-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-7-methylthieno[3,2-d]pyrimidin-4-amine Chemical compound N1=CN=C2C(C)=CSC2=C1NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 OJZLSZAYGQCTEK-UHFFFAOYSA-N 0.000 description 1
- YRFKXMUBFJVPGU-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-7h-purin-6-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC2=C3N=CN=C3N=CN2)CC1 YRFKXMUBFJVPGU-UHFFFAOYSA-N 0.000 description 1
- OTUMJJOKQMKNJO-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-9-methylpurin-6-amine Chemical compound N1=CN=C2N(C)C=NC2=C1NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 OTUMJJOKQMKNJO-UHFFFAOYSA-N 0.000 description 1
- DWHOBDRNYCOIBB-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]benzamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2C=CC=CC=2)CC1 DWHOBDRNYCOIBB-UHFFFAOYSA-N 0.000 description 1
- OHVFGEMUTFGUOR-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]bicyclo[2.2.1]hept-2-ene-5-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C2C3CC(C=C3)C2)CC1 OHVFGEMUTFGUOR-UHFFFAOYSA-N 0.000 description 1
- KWRJZKYBEXODFN-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]cyclobutanecarboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C2CCC2)CC1 KWRJZKYBEXODFN-UHFFFAOYSA-N 0.000 description 1
- BLPURSJNUZZDBX-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]cyclohexanecarboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C2CCCCC2)CC1 BLPURSJNUZZDBX-UHFFFAOYSA-N 0.000 description 1
- ZOFJDGSINAIGAX-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]furan-2-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2OC=CC=2)CC1 ZOFJDGSINAIGAX-UHFFFAOYSA-N 0.000 description 1
- LPMFADILUGHIAD-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]furan-2-carboxamide;hydrochloride Chemical compound Cl.C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2OC=CC=2)CC1 LPMFADILUGHIAD-UHFFFAOYSA-N 0.000 description 1
- YZTPNTWVGMYLQS-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]naphthalene-2-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2C=C3C=CC=CC3=CC=2)CC1 YZTPNTWVGMYLQS-UHFFFAOYSA-N 0.000 description 1
- ANTCGVOAMRTSJJ-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]pyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2N=CC=CN=2)CC1 ANTCGVOAMRTSJJ-UHFFFAOYSA-N 0.000 description 1
- ONYTZTZSTPRUHS-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]quinoxaline-2-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2N=C3C=CC=CC3=NC=2)CC1 ONYTZTZSTPRUHS-UHFFFAOYSA-N 0.000 description 1
- FSZPXCGKPJLDGK-UHFFFAOYSA-N n-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]thiophene-2-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2SC=CC=2)CC1 FSZPXCGKPJLDGK-UHFFFAOYSA-N 0.000 description 1
- GCVCTXVBOIRBAE-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-2-(2,3-dihydro-1,4-benzodioxin-3-yl)-1,3-thiazole-4-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2N=C(SC=2)C2OC3=CC=CC=C3OC2)CC1 GCVCTXVBOIRBAE-UHFFFAOYSA-N 0.000 description 1
- KQDWDIXMRXFLKT-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-2-phenoxyacetamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)COC=2C=CC=CC=2)CC1 KQDWDIXMRXFLKT-UHFFFAOYSA-N 0.000 description 1
- ZZOZJHGDXJFENS-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-3-[2-(methylamino)-2-oxoethoxy]benzamide;hydrochloride Chemical compound Cl.CNC(=O)COC1=CC=CC(C(=O)NCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 ZZOZJHGDXJFENS-UHFFFAOYSA-N 0.000 description 1
- UGTFRXYQCXLGLY-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-3-cyanobenzamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2C=C(C=CC=2)C#N)CC1 UGTFRXYQCXLGLY-UHFFFAOYSA-N 0.000 description 1
- DPCKMLABADQZQK-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-3-methylbenzamide Chemical compound CC1=CC=CC(C(=O)NCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 DPCKMLABADQZQK-UHFFFAOYSA-N 0.000 description 1
- BCXZRGJIBCYTLQ-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-3-nitrobenzamide Chemical compound [O-][N+](=O)C1=CC=CC(C(=O)NCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 BCXZRGJIBCYTLQ-UHFFFAOYSA-N 0.000 description 1
- SRSUXJTVUYNDTA-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-4-methyl-3-nitrobenzamide Chemical compound C1=C([N+]([O-])=O)C(C)=CC=C1C(=O)NCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 SRSUXJTVUYNDTA-UHFFFAOYSA-N 0.000 description 1
- VVAOLFLNBAIMMQ-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-4-methylbenzamide Chemical compound C1=CC(C)=CC=C1C(=O)NCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 VVAOLFLNBAIMMQ-UHFFFAOYSA-N 0.000 description 1
- SGGCUGPPYADYEG-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-4-nitrobenzamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)NCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 SGGCUGPPYADYEG-UHFFFAOYSA-N 0.000 description 1
- UIHNEYBTKXCMPS-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]benzamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2C=CC=CC=2)CC1 UIHNEYBTKXCMPS-UHFFFAOYSA-N 0.000 description 1
- NNTVHXHZODJAQQ-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]bicyclo[2.2.1]hept-2-ene-5-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C2C3CC(C=C3)C2)CC1 NNTVHXHZODJAQQ-UHFFFAOYSA-N 0.000 description 1
- AZAIECPMCVIVON-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]cyclohexanecarboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C2CCCCC2)CC1 AZAIECPMCVIVON-UHFFFAOYSA-N 0.000 description 1
- XOWPNWWZNRGDRP-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]furan-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2OC=CC=2)CC1 XOWPNWWZNRGDRP-UHFFFAOYSA-N 0.000 description 1
- GWUDMKBOTHPMTO-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]naphthalene-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2C=C3C=CC=CC3=CC=2)CC1 GWUDMKBOTHPMTO-UHFFFAOYSA-N 0.000 description 1
- HNMNYNMOFINIKE-UHFFFAOYSA-N n-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]thiophene-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2SC=CC=2)CC1 HNMNYNMOFINIKE-UHFFFAOYSA-N 0.000 description 1
- PNAHIPAYIBRUFT-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-1,3-benzothiazol-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2SC3=CC=CC=C3N=2)CC1 PNAHIPAYIBRUFT-UHFFFAOYSA-N 0.000 description 1
- GTMVVEHZVVCYQH-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-1,3-benzoxazol-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2OC3=CC=CC=C3N=2)CC1 GTMVVEHZVVCYQH-UHFFFAOYSA-N 0.000 description 1
- JORCUBGWXPAPNG-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-1,8-naphthyridin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=C3N=CC=CC3=CC=2)CC1 JORCUBGWXPAPNG-UHFFFAOYSA-N 0.000 description 1
- QGUVTCMYSOSXFE-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-1-methylpyrazolo[3,4-d]pyrimidin-4-amine Chemical compound N1=CN=C2N(C)N=CC2=C1NCCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 QGUVTCMYSOSXFE-UHFFFAOYSA-N 0.000 description 1
- NOWGGYMOFSIVHA-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-2,6-dimethoxypyrimidin-4-amine Chemical compound COC1=NC(OC)=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 NOWGGYMOFSIVHA-UHFFFAOYSA-N 0.000 description 1
- YLZWVBYTKXBFFI-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-2-(methylsulfanylmethyl)pyrimidin-4-amine Chemical compound CSCC1=NC=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 YLZWVBYTKXBFFI-UHFFFAOYSA-N 0.000 description 1
- CPXQTHVKAINDHE-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-2-ethylsulfanyl-6-methylpyrimidin-4-amine Chemical compound CCSC1=NC(C)=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 CPXQTHVKAINDHE-UHFFFAOYSA-N 0.000 description 1
- YWBQKEHSNGDHKJ-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-2-methylsulfanyl-6-(trifluoromethyl)pyrimidin-4-amine Chemical compound FC(F)(F)C1=NC(SC)=NC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 YWBQKEHSNGDHKJ-UHFFFAOYSA-N 0.000 description 1
- KKEHZASRXRMVEW-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-2-methylsulfanylpyrimidin-4-amine Chemical compound CSC1=NC=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 KKEHZASRXRMVEW-UHFFFAOYSA-N 0.000 description 1
- YSHXZDCGHBLWIB-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4,6-dimethoxypyrimidin-2-amine Chemical compound COC1=CC(OC)=NC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 YSHXZDCGHBLWIB-UHFFFAOYSA-N 0.000 description 1
- WVOAEJYFEHFEIU-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-(furan-3-yl)pyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=C(C=CN=2)C2=COC=C2)CC1 WVOAEJYFEHFEIU-UHFFFAOYSA-N 0.000 description 1
- IUKWUWOTBICNEV-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-(trifluoromethyl)pyrimidin-2-amine Chemical compound FC(F)(F)C1=CC=NC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 IUKWUWOTBICNEV-UHFFFAOYSA-N 0.000 description 1
- WPYKSZLRMQEQSG-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-phenylpyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=C(C=CN=2)C=2C=CC=CC=2)CC1 WPYKSZLRMQEQSG-UHFFFAOYSA-N 0.000 description 1
- WWOINECOLZVMKL-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-propylsulfanylpyrimidin-2-amine Chemical compound CCCSC1=CC=NC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 WWOINECOLZVMKL-UHFFFAOYSA-N 0.000 description 1
- NQSGHKUNRWAANG-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-pyridin-3-ylpyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=C(C=CN=2)C=2C=NC=CC=2)CC1 NQSGHKUNRWAANG-UHFFFAOYSA-N 0.000 description 1
- LULOKMHNHCLNTA-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-thiophen-2-ylpyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=C(C=CN=2)C=2SC=CC=2)CC1 LULOKMHNHCLNTA-UHFFFAOYSA-N 0.000 description 1
- YRGRRKBIZLQZEY-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-thiophen-3-ylpyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=C(C=CN=2)C2=CSC=C2)CC1 YRGRRKBIZLQZEY-UHFFFAOYSA-N 0.000 description 1
- OGGFUYHLQSDNBL-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-5-methoxy-2-methylpyrimidin-4-amine Chemical compound COC1=CN=C(C)N=C1NCCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 OGGFUYHLQSDNBL-UHFFFAOYSA-N 0.000 description 1
- KYRIOZQSGUKCBI-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-5-methoxy-2-methylsulfanylpyrimidin-4-amine Chemical compound COC1=CN=C(SC)N=C1NCCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 KYRIOZQSGUKCBI-UHFFFAOYSA-N 0.000 description 1
- QKBVECZBMTUOCW-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-5-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C=12C(C)=CSC2=NC=NC=1NCCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 QKBVECZBMTUOCW-UHFFFAOYSA-N 0.000 description 1
- CENUZHTZTUCONP-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-6-methyl-2-methylsulfanylpyrimidin-4-amine Chemical compound CSC1=NC(C)=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 CENUZHTZTUCONP-UHFFFAOYSA-N 0.000 description 1
- NTTHUHDBOMNZQH-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-6-methylpyridin-2-amine Chemical compound CC1=CC=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 NTTHUHDBOMNZQH-UHFFFAOYSA-N 0.000 description 1
- MPDOZIITBQYNNJ-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-7-methylthieno[3,2-d]pyrimidin-4-amine Chemical compound N1=CN=C2C(C)=CSC2=C1NCCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 MPDOZIITBQYNNJ-UHFFFAOYSA-N 0.000 description 1
- YBPQRVURRORWIE-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-7h-purin-6-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC2=C3N=CN=C3N=CN2)CC1 YBPQRVURRORWIE-UHFFFAOYSA-N 0.000 description 1
- NCDKWNZTPAKVCQ-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-9-methylpurin-6-amine Chemical compound N1=CN=C2N(C)C=NC2=C1NCCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 NCDKWNZTPAKVCQ-UHFFFAOYSA-N 0.000 description 1
- VODYKEUGXCHTEC-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]pyridin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=CC=CC=2)CC1 VODYKEUGXCHTEC-UHFFFAOYSA-N 0.000 description 1
- AXGODTPMEJUMJX-UHFFFAOYSA-N n-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]pyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=CC=CN=2)CC1 AXGODTPMEJUMJX-UHFFFAOYSA-N 0.000 description 1
- RUHMSOCBISJCEB-UHFFFAOYSA-N n-[4-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 RUHMSOCBISJCEB-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9901117A SE9901117D0 (sv) | 1999-03-26 | 1999-03-26 | Novel compounds |
| SE9901117-3 | 1999-03-26 | ||
| SE9902194A SE9902194D0 (sv) | 1999-06-10 | 1999-06-10 | Novel compounds |
| SE9902194-1 | 1999-06-10 | ||
| PCT/SE2000/000563 WO2000058305A1 (en) | 1999-03-26 | 2000-03-22 | Novel compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002540204A JP2002540204A (ja) | 2002-11-26 |
| JP2002540204A5 true JP2002540204A5 (enExample) | 2007-04-26 |
Family
ID=26663543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000608007A Pending JP2002540204A (ja) | 1999-03-26 | 2000-03-22 | 新規化合物 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US6518286B1 (enExample) |
| EP (1) | EP1165545A1 (enExample) |
| JP (1) | JP2002540204A (enExample) |
| KR (1) | KR20010108394A (enExample) |
| CN (1) | CN1344266A (enExample) |
| AU (1) | AU4157500A (enExample) |
| BR (1) | BR0009338A (enExample) |
| CA (1) | CA2361366A1 (enExample) |
| CZ (1) | CZ20013451A3 (enExample) |
| EE (1) | EE200100502A (enExample) |
| HU (1) | HUP0202017A3 (enExample) |
| IL (1) | IL144353A0 (enExample) |
| IS (1) | IS6024A (enExample) |
| NO (1) | NO20014518D0 (enExample) |
| PL (1) | PL350904A1 (enExample) |
| SK (1) | SK11822001A3 (enExample) |
| TR (1) | TR200102800T2 (enExample) |
| WO (1) | WO2000058305A1 (enExample) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EE200100502A (et) | 1999-03-26 | 2002-12-16 | Astrazeneca Ab | Ühendid |
| SE9902987D0 (sv) | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
| DE19952147A1 (de) * | 1999-10-29 | 2001-05-03 | Boehringer Ingelheim Pharma | Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| GB0004151D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
| GB0004152D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel compounds |
| GB0004153D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
| CO5300399A1 (es) | 2000-02-25 | 2003-07-31 | Astrazeneca Ab | Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen |
| GB0013060D0 (en) | 2000-05-31 | 2000-07-19 | Astrazeneca Ab | Chemical compounds |
| AR028948A1 (es) | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | Compuestos novedosos |
| US7005439B2 (en) | 2000-06-20 | 2006-02-28 | Astrazeneca Ab | Compounds |
| TWI227231B (en) * | 2000-07-12 | 2005-02-01 | Novartis Ag | 4-benzoyl-piperidine derivatives for treating conditions mediated by CCR-3 |
| GB0021670D0 (en) * | 2000-09-04 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
| AU2002215928A1 (en) * | 2000-10-09 | 2002-04-22 | Novartis Pharma Gmbh | N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3 receptor antagonists |
| US7034042B2 (en) | 2000-10-09 | 2006-04-25 | Novartis Ag | N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR33 receptor antagonists |
| UY27003A1 (es) | 2000-11-06 | 2002-07-31 | Schering Ag | Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer |
| GB0104050D0 (en) | 2001-02-19 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
| AR035230A1 (es) | 2001-03-19 | 2004-05-05 | Astrazeneca Ab | Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos |
| GB0107228D0 (en) | 2001-03-22 | 2001-05-16 | Astrazeneca Ab | Chemical compounds |
| SE0101038D0 (sv) | 2001-03-23 | 2001-03-23 | Astrazeneca Ab | Novel compounds |
| US7115635B2 (en) | 2001-04-27 | 2006-10-03 | Mitsubishi Pharma Corporation | Benzylpiperidine compound |
| GB0114699D0 (en) * | 2001-06-15 | 2001-08-08 | Novartis Ag | Organic compounds |
| GB0117387D0 (en) * | 2001-07-17 | 2001-09-05 | Novartis Ag | Organic compounds |
| GB0117899D0 (en) | 2001-07-23 | 2001-09-12 | Astrazeneca Ab | Chemical compounds |
| SE0102640D0 (sv) | 2001-07-31 | 2001-07-31 | Astrazeneca Ab | Novel compounds |
| SE0102809D0 (sv) * | 2001-08-22 | 2001-08-22 | Astrazeneca Ab | Novel compounds |
| SE0103818D0 (sv) | 2001-11-15 | 2001-11-15 | Astrazeneca Ab | Chemical compounds |
| TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| TW200303304A (en) | 2002-02-18 | 2003-09-01 | Astrazeneca Ab | Chemical compounds |
| CN103169708B (zh) | 2002-07-29 | 2018-02-02 | 里格尔药品股份有限公司 | 用2,4‑嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法 |
| KR101297924B1 (ko) * | 2002-07-29 | 2013-08-20 | 리겔 파마슈티칼스, 인크. | 2,4-피리미딘디아민 화합물을 이용한 자가면역질환의 치료및 예방 방법 |
| EP2130541A3 (en) * | 2002-07-29 | 2013-12-18 | Rigel Pharmaceuticals, Inc. | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| WO2004048343A1 (en) * | 2002-11-28 | 2004-06-10 | Schering Aktiengesellschaft | Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| CN1744899A (zh) * | 2002-12-13 | 2006-03-08 | 史密丝克莱恩比彻姆公司 | 作为ccr5拮抗剂的哌啶衍生物 |
| EP2385040A1 (en) | 2003-03-14 | 2011-11-09 | ONO Pharmaceutical Co., Ltd. | Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| US7498323B2 (en) | 2003-04-18 | 2009-03-03 | Ono Pharmaceuticals Co., Ltd. | Spiro-piperidine compounds and medicinal use thereof |
| SE0301369D0 (sv) | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | Chemical compounds |
| US7122542B2 (en) | 2003-07-30 | 2006-10-17 | Rigel Pharmaceuticals, Inc. | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| WO2005040129A2 (en) * | 2003-10-24 | 2005-05-06 | F. Hoffmann-La Roche Ag | Ccr3 receptor antagonists |
| SE0400208D0 (sv) | 2004-02-02 | 2004-02-02 | Astrazeneca Ab | Chemical compounds |
| GB0412468D0 (en) * | 2004-06-04 | 2004-07-07 | Astrazeneca Ab | Chemical compounds |
| BRPI0512535A (pt) | 2004-06-24 | 2008-03-25 | Incyte Corp | compostos de piperidinas n-substituìdas, suas composições e métodos de modulações |
| KR101011848B1 (ko) | 2004-09-08 | 2011-02-01 | 미쓰비시 타나베 파마 코퍼레이션 | 모르폴린 화합물 |
| WO2006030925A1 (ja) | 2004-09-13 | 2006-03-23 | Ono Pharmaceutical Co., Ltd. | 含窒素複素環誘導体およびそれらを有効成分とする薬剤 |
| ATE540035T1 (de) | 2004-11-24 | 2012-01-15 | Rigel Pharmaceuticals Inc | Spiro-2,4-pyrimidindiamin-verbindungen und ihre verwendungen |
| US7576080B2 (en) * | 2004-12-23 | 2009-08-18 | Memory Pharmaceuticals Corporation | Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
| EP1889622A4 (en) | 2005-05-31 | 2009-12-23 | Ono Pharmaceutical Co | SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF |
| CA2612325A1 (en) * | 2005-06-15 | 2006-12-28 | Anormed Inc. | Chemokine receptor binding compounds |
| TW200738634A (en) | 2005-08-02 | 2007-10-16 | Astrazeneca Ab | New salt |
| JP5251127B2 (ja) | 2005-10-28 | 2013-07-31 | 小野薬品工業株式会社 | 塩基性基を含有する化合物およびその用途 |
| TW200800895A (en) * | 2005-11-02 | 2008-01-01 | Astrazeneca Ab | Novel compounds |
| PL1961744T3 (pl) | 2005-11-18 | 2013-09-30 | Ono Pharmaceutical Co | Związek zawierający grupę zasadową oraz jego zastosowanie |
| RU2396265C2 (ru) | 2006-02-17 | 2010-08-10 | Ф. Хоффманн-Ля Рош Аг | Производные бензоилпиперидина в качестве модуляторов рецепторов 5ht2 и d3 |
| EP1994003A4 (en) * | 2006-03-07 | 2009-12-02 | Astrazeneca Ab | PIPERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEY |
| EP1994002A1 (en) * | 2006-03-07 | 2008-11-26 | AstraZeneca AB | Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| US8003642B2 (en) | 2006-03-10 | 2011-08-23 | Ono Pharmaceutical Co., Ltd. | Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| EP2042503B1 (en) | 2006-05-16 | 2013-01-30 | Ono Pharmaceutical Co., Ltd. | Compound having acidic group which may be protected, and use thereof |
| WO2007146981A2 (en) * | 2006-06-15 | 2007-12-21 | Boehringer Ingelheim International Gmbh | 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha |
| CN101506176A (zh) | 2006-06-15 | 2009-08-12 | 贝林格尔.英格海姆国际有限公司 | 2-苯胺基-4-氨基亚烷基氨基嘧啶 |
| EP2055705A4 (en) | 2006-07-31 | 2014-08-20 | Ono Pharmaceutical Co | COMPOUND WITH A CYCLIC GROUP BOUND BY A SPIRO BINDING THEREOF AND APPLY THEREOF |
| EP2079693B1 (en) | 2006-10-31 | 2013-02-27 | F. Hoffmann-La Roche AG | Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| WO2008097976A1 (en) * | 2007-02-09 | 2008-08-14 | Kalypsys, Inc. | Heterocyclic modulators of tgr5 for treatment of disease |
| KR20090115953A (ko) * | 2007-03-06 | 2009-11-10 | 노파르티스 아게 | 염증성 또는 알레르기성 상태의 치료에 적합한 바이시클릭 유기 화합물 |
| JP5539190B2 (ja) * | 2007-06-12 | 2014-07-02 | エフ．ホフマン−ラ ロシュ アーゲー | チアゾロピリミジン類及びホスファチジルイノシトール−３キナーゼのインヒビターとしてのそれらの使用 |
| ES2399774T3 (es) * | 2007-09-24 | 2013-04-03 | Genentech, Inc. | Compuestos de tiazolopirimidina inhibidores de PI3K y métodos de uso |
| ES2842289T3 (es) | 2008-02-29 | 2021-07-13 | Vm Therapeutics Llc | Compuestos para tratar el síndrome del dolor y otros trastornos |
| WO2010129351A1 (en) | 2009-04-28 | 2010-11-11 | Schepens Eye Research Institute | Method to identify and treat age-related macular degeneration |
| CN104918940B (zh) * | 2012-11-16 | 2017-03-08 | 默沙东公司 | 人磷脂酰肌醇3‑激酶δ的嘌呤抑制剂 |
| CN111004218B (zh) * | 2018-10-08 | 2023-10-13 | 沈阳中化农药化工研发有限公司 | 含哌啶的嘧啶类化合物及用途 |
| US10702525B1 (en) * | 2019-09-04 | 2020-07-07 | United Arab Emirates University | Pyrimidine derivatives as anti-diabetic agents |
| WO2021217143A1 (en) * | 2020-04-24 | 2021-10-28 | Emory University | Aminopiperidine amides, derivatives, compositions, and uses related to cxcr4 modulation |
| JP2023528546A (ja) * | 2020-05-29 | 2023-07-04 | テグ－キョンプク メディカル イノベーション ファウンデーション | カルボキサミド誘導体およびそれを有効成分とする精神病の予防または治療に使用するための医薬組成物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4335127A (en) * | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
| DK159420C (da) | 1983-03-09 | 1991-03-11 | Ciba Geigy Ag | N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater |
| IL76366A (en) | 1984-09-14 | 1989-07-31 | Ciba Geigy Ag | 2,6-dialkyl-4-aryl-3,5-diacyl-1,4-dihydropyridine derivatives,processes for their manufacture and pharmaceutical preparations containing them |
| CA1246074A (en) * | 1984-12-05 | 1988-12-06 | Albertus H.M.T. Van Heertum | Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines |
| KR910006138B1 (ko) | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
| JP2860689B2 (ja) * | 1990-03-14 | 1999-02-24 | 第一製薬株式会社 | ピリミジン誘導体 |
| FR2667317B1 (fr) | 1990-10-02 | 1992-12-04 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. |
| US5143923B1 (en) * | 1991-04-29 | 1993-11-02 | Hoechst-Roussel Pharmaceuticals Incorporated | Benzoisothiazole-and benzisoxazole-3-carboxamides |
| FR2724382B1 (fr) | 1994-09-13 | 1996-10-18 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique |
| EP0816362A4 (en) * | 1995-03-22 | 1998-07-08 | Taisho Pharmaceutical Co Ltd | THIAZOLE DERIVATIVES |
| JPH0940646A (ja) | 1995-07-27 | 1997-02-10 | Yamanouchi Pharmaceut Co Ltd | ベンゼン縮合環誘導体又はその塩 |
| JPH0977742A (ja) | 1995-09-12 | 1997-03-25 | Kyorin Pharmaceut Co Ltd | 新規なベンズアミド誘導体 |
| JP2000506904A (ja) | 1996-05-16 | 2000-06-06 | シナプティック・ファーマスーティカル・コーポレーション | ジヒドロピリミジン類およびその使用 |
| IL125658A0 (en) * | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| EP1047675A1 (en) * | 1998-01-21 | 2000-11-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6613905B1 (en) * | 1998-01-21 | 2003-09-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| JP3475177B2 (ja) * | 1998-11-17 | 2003-12-08 | エフ．ホフマン−ラ ロシュ アーゲー | ４−アロイルピペリジンｃｃｒ−３受容体拮抗剤ｉｉｉ |
| EE200100502A (et) | 1999-03-26 | 2002-12-16 | Astrazeneca Ab | Ühendid |
-
2000
- 2000-03-22 EE EEP200100502A patent/EE200100502A/xx unknown
- 2000-03-22 CN CN00805451A patent/CN1344266A/zh active Pending
- 2000-03-22 PL PL00350904A patent/PL350904A1/xx not_active Application Discontinuation
- 2000-03-22 EP EP00921237A patent/EP1165545A1/en not_active Withdrawn
- 2000-03-22 TR TR2001/02800T patent/TR200102800T2/xx unknown
- 2000-03-22 SK SK1182-2001A patent/SK11822001A3/sk unknown
- 2000-03-22 KR KR1020017012174A patent/KR20010108394A/ko not_active Withdrawn
- 2000-03-22 JP JP2000608007A patent/JP2002540204A/ja active Pending
- 2000-03-22 HU HU0202017A patent/HUP0202017A3/hu unknown
- 2000-03-22 IL IL14435300A patent/IL144353A0/xx unknown
- 2000-03-22 AU AU41575/00A patent/AU4157500A/en not_active Abandoned
- 2000-03-22 CZ CZ20013451A patent/CZ20013451A3/cs unknown
- 2000-03-22 BR BR0009338-6A patent/BR0009338A/pt not_active IP Right Cessation
- 2000-03-22 CA CA002361366A patent/CA2361366A1/en not_active Abandoned
- 2000-03-22 US US09/555,565 patent/US6518286B1/en not_active Expired - Fee Related
- 2000-03-22 WO PCT/SE2000/000563 patent/WO2000058305A1/en not_active Ceased
-
2001
- 2001-07-26 IS IS6024A patent/IS6024A/is unknown
- 2001-09-17 NO NO20014518A patent/NO20014518D0/no unknown
-
2003
- 2003-01-09 US US10/339,261 patent/US6946478B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002540204A5 (enExample) | ||
| CN1344266A (zh) | 新的化合物 | |
| RU2011116226A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| ES2255119T3 (es) | Antagonistas del receptor ccr-3. | |
| JP2007513957A5 (enExample) | ||
| KR101078505B1 (ko) | 질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는약제 | |
| JP2007519754A5 (enExample) | ||
| JP2005533803A5 (enExample) | ||
| RU2006139952A (ru) | Производные 1-аминофталазина, их получение и их применение в терапии | |
| JP2003507328A5 (enExample) | ||
| JP2004509953A5 (enExample) | ||
| SK82398A3 (en) | 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists | |
| RU2005134006A (ru) | Производные 4-(4-{гетероциклилалкокси}фенил0-1-(гетероциклилкарбонил)пиперидина и родственные соединения как антагонисты гистамина н3 для лечения неврологических заболеваний, таких как болезнь альцгеймера | |
| JP2005526723A5 (enExample) | ||
| SK16152002A3 (sk) | Farmacueticky účinné piperidínové deriváty, najmä ako modulátory aktivity chemokínového receptora | |
| RU2004127925A (ru) | N3-алкилированные бензимидазольные производные в качестве ингибиторов мек | |
| RU2006124518A (ru) | Ингибиторы фосфодиэстеразы 4, включая аналоги n-замещенного диариламина | |
| RU2015150946A (ru) | Новые соединения для селективных ингибиторов гистондеацетилазы и фармацевтическая композиция, включающая такие соединения | |
| JP2007519753A5 (enExample) | ||
| RU2011116232A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| CN1268124A (zh) | 酰基－哌嗪基－嘧啶衍生物,它们的制备和作为药物的应用 | |
| CZ20024200A3 (cs) | Substituované 1-aminoalkyllaktamy a jejich použití jako antagonisty muskarinového receptoru | |
| JP2007500700A5 (enExample) | ||
| CA2321198A1 (en) | 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists | |
| JP2012507525A5 (enExample) |